Roundtable on De-linking R&D Incentives from Prices: Designing Innovation Inducement Prizes for Diagnostics, New Drugs and Vaccines for Type II and III diseases and conditions, with a particular focus on TB and Chagas Disease
The meeting is going to be small with around 40 high level policy makers and technical participants, including industry, donors, civil society and government officials.
Continue Reading →
TransAtlantic Consumer Dialogue, Washington, DC.
The TACD conference on Patents, Copyrights and Knowledge Governance: the next fours years is going to be held on January 12-13th, 2009 in Washington, DC.
Venue: Carnegie Institution of Washington • 1530 P Street NW • Washington, DC 20005
The event is free and is now open for registrations on the TACD website: http://www.tacd.org/events/patents_2009.htm
Continue Reading →
This was the title the Washington Post today gave the AP story.
This was the title of the FTC Press release:
Continue Reading →
This is from an exchange on IP-Health.
———–
Dear Aidan and Thomas.
There are several things I could mention about this revised position on compulsory licenses, but I will begin with these.
Continue Reading →
This is a comment on the references to compulsory licensing in the Hollis/Pogge HIF book that are quoted below.
https://www.keionline.org/blogs/2008/11/18/excerpts-from-hif-compulsory-licensing/
Aidan Hollis and Thomas Pogge, The Health Impact Fund, Making New Medicines Accessible for All, A Report of Incentives for Global Health, 2008.
Continue Reading →
In an exchange on the i+a listserve, I asked Professor Pogge if the decision to reject open licensing was in part because he was concerned about opposition from certain elements of the pharmaceutical industry. This was his response, shared here with permission:
Continue Reading →
WHO has announced the names for the Expert Working Group on R&D financing
We don’t know everyone on the list, but for the people that we do know, we are generally impressed. The WHO seems to have created a body with considerable expertise and reputation, and included people who will consider new ideas. This seems like a very good start.
http://www.who.int/phi/R_Dfinancing/en/index.html
Continue Reading →
At KEI Washington, DC offices
US Priority Review Voucher
Time: 12:00pm-2:30pm, Thursday, 13 November 2008
Knowledge Ecology International (formerly CPTech)
1621 Connecticut Avenue NW, Suite 500 (5th Floor)
Washington DC, 20009
Tel: +1 202 332 2670
PARTICIPANTS
Aaron Kesselheim , Brigham and Women's Hospital/Harvard School of Public Health, Harvard University
David Ridley , The Fuqua School of Business, Duke University
James Love, KEI Continue Reading →
The World Intellectual Property Organization (WIPO) divides its norm setting work among several committees. The 17th meeting of the Standing Committee on Copyright and Related Rights (SCCR) met last week, and considered several topics, including the first in-depth effort to consider a work program on limitations and exceptions for copyright. This work program, first proposed formally by Chile (SCCR/13/5) among WIPO member states, is a work in progress. Continue Reading →
